Robert J. Terifay, SVP Commercial at REGENERON PHARMACEUTICALS INC (REGN), sold 20,000 shares at $74.20 ($1.5M) on 2012-01-11, disclosed to the SEC on 2012-01-11.
Scheduled sale ($1.5M) by SVP Commercial under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $73.92 | 543 | $40K | 2.7% |
| 2 | $73.92 | 554 | $41K | 2.8% |
| 3 | $73.92 | 4,651 | $344K | 23.2% |
| 4 | $73.92 | 5,233 | $387K | 26.1% |
| 5 | $74.20 | 9,019 | $669K | 45.2% |
| Total | $74.05 avg | 20,000 |
| $1.5M |
| 100% |
| Filing → |
| REGN | SELL | 2015-03-18 | $5.0M | — | Filing → |
| REGN | SELL | 2015-02-25 | $4.7M | — | Filing → |
| REGN | SELL | 2014-11-19 | $9.1M | — | Filing → |